Furthermore, it is unclear how well-established decreases in inflammatory markers like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) translate into significant decreases in CV events or surrogate indicators of atherosclerosis [11]. The gene discussed is CRP; the disease is atherosclerosis.